Asthma, COPD, Lung Cancer News | Treatment & Research Articles
WEBRegular SARS-CoV-2 Testing in Hemodialysis Facilities Unacceptable to Most Patients. Adiposity in Midlife Linked to PFAS Exposure During Pregnancy. Treatment-Resistant Depression Treatment Response Relies on Sleep Quality. Children Developing Asthma Have Lower IL-10 Levels by Age 6 Years. Lumacaftor/Ivacaftor for CF in …
Updated 2023 GOLD Report Revises COPD Definitions and …
WEBJan 20, 2023 · The 2023 report from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) — “Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease” (COPD) 1 — details “an expanded range of therapies for COPD that now can be considered to improve mortality,” according to Gerard J. Criner, MD, FACP, FACCP, an author of the 2023 GOLD ...
2024 GOLD Report Reflects New Research on COPD Management
WEBDec 8, 2023 · Shifts in Thinking About COPD. Although many changes in the 2024 report reflect new research released from January 2022 to July 2023 (148 new references in total), the updated report does more than just incorporate this new research, said Dr Vogelmeier. The new “consolidated” report continues to refine the definition of COPD and pre-COPD ...
GINA 2024 Asthma Update: Revised Recommendations on …
WEBJun 28, 2024 · The GINA 2024 asthma update includes new guidance on medications, monitoring, treatment goals, remission, cough variant asthma, children, and more.
Dupixent Approved as Add-On Maintenance Therapy in COPD
WEBOct 1, 2024 · The Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance therapy for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.. The approval was supported by data from the randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS (ClinicalTrials.gov Identifier ...
2022 Clinical Guidelines for Pulmonary ... - Pulmonology Advisor
WEBOctober 21, 2022. New clinical guidelines for the diagnosis and treatment of patients with pulmonary hypertension (PH) include an algorithm for earlier detection in the community and a recommendation for expedited referral for high-risk or complex patients. The guidelines were published simultaneously in the European Respiratory Journal and the ...
Diagnosis & Disease Information - Pulmonology Advisor
WEBThoracentesis. Thoracentesis, also known as a pleural tap, is a minimally invasive procedure performed to remove fluid or air from the pleural space surrounding the lungs. Thoracentesis is used to obtain a fluid sample for diagnosing and/or treating various health conditions, including pleural effusions, cancer, and pneumothoraces.
Chronic Obstructive Pulmonary Disease (COPD) - Pulmonology …
WEBNov 15, 2023 · Overview. Chronic obstructive pulmonary disease (COPD) refers to a group of conditions that include emphysema and chronic bronchitis and is characterized by progressive airflow limitation and tissue destruction. 1 It is associated with structural changes in the lungs due to chronic inflammation, typically caused by prolonged exposure to …
Dupilumab Reduces Symptoms, Exacerbations in COPD With T2 …
WEBOctober 12, 2023. The annual rate of moderate to severe exacerbations was reduced by 30% in patients with COPD and T2 inflammation who received dupilumab. Dupilumab (DPL) is associated with improved lung function, health-related quality of life, and symptoms in patients with chronic obstructive pulmonary disease (COPD) with type 2 (T2 ...
Viral Pneumonia | Diagnosis & Disease Information - Pulmonology …
WEBApr 12, 2024 · Viral pneumonia, a lung infection caused by a virus, is most commonly caused by influenza virus, respiratory syncytial virus (RSV), parainfluenza virus, measles virus, and coronaviruses. 1 As viral pandemics increasingly affect the global population — as seen in recent years with severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 ...